Analysis of clinical characteristics of psittacosis and construction of diagnostic predictive model

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045952

Enrollment

Unknown

Registered

2021-04-30

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psittacosis pneumonia

Interventions

Healthy individuals with no underlying disease, no history of smoking, and other patients with community-acquired pneumonia:Nil

Patients with psittacosis pneumonia :no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with psittacosis pneumonia diagnosed by mngs in Xiangya Third Hospital of Central South University since December 2018.

Exclusion criteria

Exclusion criteria: Accompanied by patients with serious illness.

Design outcomes

Primary

Measure	Time frame
Metagenomic next-generation sequencing;Blood routine;liver function;kidney function;Coagulation routine;Brain natriuretic peptide;Cardiac troponin;Tumor necrosis factor ;Interleukin 2(IL 2);Interleukin 12(IL 12);Pulmonary imaging;Sputum culture;Sequential organ failure score(SOFA);Acute Physiology and Chronic Health Score(APACHE II);Glasgow coma(GCS);Blood gas analysis;	—

Countries

China

Contacts

Public ContactXie Lihua

The Third Xiangya Hospital of Central South University

13397219@qq.com+86 13787143364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026